ArticleDiabetes2025

Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell-Derived β-Cells Harboring a Partially Functional WFS1 Variant.

Silvia Torchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.